Christopher J. Matheson

1.3k total citations
22 papers, 977 citations indexed

About

Christopher J. Matheson is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Christopher J. Matheson has authored 22 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Christopher J. Matheson's work include Computational Drug Discovery Methods (4 papers), Microtubule and mitosis dynamics (4 papers) and Melanoma and MAPK Pathways (4 papers). Christopher J. Matheson is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Microtubule and mitosis dynamics (4 papers) and Melanoma and MAPK Pathways (4 papers). Christopher J. Matheson collaborates with scholars based in United States, United Kingdom and Australia. Christopher J. Matheson's co-authors include Philip Reigan, Donald S. Backos, Steffanie L. Furtek, Roger J. Griffin, Christopher R. Coxon, Céline Cano, David M. Turner, Bernard T. Golding, Ian R. Hardcastle and Andrew M. Donson and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Trends in Pharmacological Sciences.

In The Last Decade

Christopher J. Matheson

21 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Matheson United States 13 647 442 137 130 128 22 977
Maurizia Dalla Palma Italy 11 750 1.2× 454 1.0× 142 1.0× 82 0.6× 96 0.8× 19 974
Peter Drueckes Switzerland 15 727 1.1× 290 0.7× 87 0.6× 173 1.3× 96 0.8× 24 1.2k
Kevin Hudson United Kingdom 17 779 1.2× 223 0.5× 76 0.6× 132 1.0× 156 1.2× 30 1.1k
Nanni Huser United States 8 737 1.1× 238 0.5× 73 0.5× 79 0.6× 84 0.7× 15 999
Martina S.J. McDermott United States 16 488 0.8× 438 1.0× 80 0.6× 104 0.8× 172 1.3× 33 969
Kee Chuan Goh Singapore 16 596 0.9× 389 0.9× 82 0.6× 154 1.2× 72 0.6× 26 1.1k
Krishna G. Vijayendran United States 5 604 0.9× 298 0.7× 105 0.8× 195 1.5× 69 0.5× 5 847
Richard Gowan United States 6 706 1.1× 315 0.7× 125 0.9× 139 1.1× 94 0.7× 7 944
Rooha Contractor United States 14 870 1.3× 469 1.1× 93 0.7× 214 1.6× 91 0.7× 24 1.3k
Kate F. Byth United States 15 520 0.8× 400 0.9× 116 0.8× 228 1.8× 152 1.2× 20 1.0k

Countries citing papers authored by Christopher J. Matheson

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Matheson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Matheson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Matheson more than expected).

Fields of papers citing papers by Christopher J. Matheson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Matheson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Matheson. The network helps show where Christopher J. Matheson may publish in the future.

Co-authorship network of co-authors of Christopher J. Matheson

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Matheson. A scholar is included among the top collaborators of Christopher J. Matheson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Matheson. Christopher J. Matheson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matheson, Christopher J., et al.. (2021). N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors. Bioorganic & Medicinal Chemistry. 41. 116220–116220. 8 indexed citations
3.
Matheson, Christopher J., et al.. (2021). Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation. ACS Chemical Neuroscience. 12(18). 3477–3486. 2 indexed citations
4.
Matheson, Christopher J., Christopher R. Coxon, Richard Bayliss, et al.. (2020). 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. RSC Medicinal Chemistry. 11(6). 707–731. 14 indexed citations
5.
Matheson, Christopher J., et al.. (2020). Substituted pteridinones as p90 ribosomal S6 protein kinase (RSK) inhibitors: A structure-activity study. Bioorganic & Medicinal Chemistry. 28(5). 115303–115303. 10 indexed citations
6.
Matheson, Christopher J., et al.. (2020). Substituted oxindol-3-ylidenes as AMP-activated protein kinase (AMPK) inhibitors. European Journal of Medicinal Chemistry. 197. 112316–112316. 20 indexed citations
7.
Matheson, Christopher J., et al.. (2020). Molecular docking of substituted pteridinones and pyrimidines to the ATP-binding site of the N-terminal domain of RSK2 and associated MM/GBSA and molecular field datasets. SHILAP Revista de lepidopterología. 29. 105347–105347. 23 indexed citations
8.
Matheson, Christopher J., et al.. (2017). Selective Targeting of RSK Isoforms in Cancer. Trends in cancer. 3(4). 302–312. 54 indexed citations
9.
Matheson, Christopher J., Sujatha Venkataraman, Vladimir Amani, et al.. (2016). A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells. ACS Chemical Biology. 11(4). 921–930. 48 indexed citations
10.
Tabakoff, Boris, Wen-Hua Ren, Lauren A. Vanderlinden, et al.. (2016). A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain. European Journal of Pharmacology. 784. 1–14. 6 indexed citations
11.
Matheson, Christopher J., Donald S. Backos, & Philip Reigan. (2016). Targeting WEE1 Kinase in Cancer. Trends in Pharmacological Sciences. 37(10). 872–881. 306 indexed citations
12.
Furtek, Steffanie L., Donald S. Backos, Christopher J. Matheson, & Philip Reigan. (2016). Strategies and Approaches of Targeting STAT3 for Cancer Treatment. ACS Chemical Biology. 11(2). 308–318. 310 indexed citations
13.
Coxon, Christopher R., Christopher Wong, Richard Bayliss, et al.. (2016). Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget. 8(12). 19089–19124. 12 indexed citations
14.
Xiong, Weipeng, Christopher J. Matheson, Mei Xu, et al.. (2016). Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors. Molecular Cancer Therapeutics. 15(3). 412–420. 18 indexed citations
15.
Martinez, Eliana C., Catherine Passariello, Jinliang Li, et al.. (2015). RSK3: A regulator of pathological cardiac remodeling. IUBMB Life. 67(5). 331–337. 15 indexed citations
16.
Carbain, Benoît, Christopher R. Coxon, Honorine Lebraud, et al.. (2014). Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates SNAr Reactions of Heterocycles with Arylamines. Chemistry - A European Journal. 20(8). 2311–2317. 31 indexed citations
17.
Krueger, Aaron, David Drasin, Wendy Lea, et al.. (2014). Allosteric Inhibitors of the Eya2 Phosphatase Are Selective and Inhibit Eya2-mediated Cell Migration. Journal of Biological Chemistry. 289(23). 16349–16361. 43 indexed citations
18.
Lebraud, Honorine, Christopher R. Coxon, Benoît Carbain, et al.. (2013). Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles. Organic & Biomolecular Chemistry. 12(1). 141–148. 21 indexed citations
19.
Carbain, Benoît, Richard Bayliss, K. Boxall, et al.. (2012). 118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2. European Journal of Cancer. 48. 37–37. 3 indexed citations
20.
Matheson, Christopher J., et al.. (1988). Images of Lawrence. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizia Dalla Palma Breakdown of academic impact, for papers by Peter Drueckes Breakdown of academic impact, for papers by Kevin Hudson Breakdown of academic impact, for papers by Nanni Huser Breakdown of academic impact, for papers by Martina S.J. McDermott Breakdown of academic impact, for papers by Kee Chuan Goh Breakdown of academic impact, for papers by Krishna G. Vijayendran Breakdown of academic impact, for papers by Richard Gowan Breakdown of academic impact, for papers by Rooha Contractor Breakdown of academic impact, for papers by Kate F. Byth
Rankless by CCL
2026